OptiBiotix Health's (LON:OPTI) Stephen O'Hara caught up with Proactive London's Andrew Scott following the news they've signed a distribution deal covering Australia, New Zealand, Indonesia, and Thailand for its cholesterol and blood pressure reducing dietary supplements, CholBiome and CholBiome X3. It's with Actial Farmaceutica - an Italian business with operations in Asia focused on probiotics and gut health. O'Hara also expands on the announcement from earlier this week around the launch of WellBiome, a blend of fibres and minerals to promote the diversity of the gut microbiome.
01 Jul 20